Health Canada approves weight-loss drug for sleep apnea in patients with obesity

Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.

The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing temporarily because their upper airway is blocked.

That blockage can […] ...